Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Let's say that JnJ and DECN agree on a settlement next week, will the shareholders be told what it is ... in detail ... immediately?
Ten shares have traded pre-market up .57 to 4.00.
Head fake or what?
And where does it say tha the strips in the ad my link lead s to can't be sold in the US. It doesn't say it anywhere.
Fifty One Step glucose test strips are available in the United States for $23.79. Period. Nop matter how many times you say differently, my link proves it to be true.
That's just total obfuscation, to put it politely, implosion. The links I posted are to the actual Amazon pages to buy both One Step and Genultimate in the United States of America in U.S. Dollars.
Fifty One Step strips cost $23.79 with free shipping from Amazon.
Why the gross exaggeration?
Of course the price of off-brand Genstrips are going to be cheaper than One Touch by why the huge exaggeration of the price difference:
Here is 50 Genstrips at Amazon for $12.80
Here is 50 One Touch strips for $23.79
Then I agree with the poster who said that JNJ should just buy Genultimate and rebox them.
As if.
Actually, JNJ strips are $39.99 for 50, not 25 strips.
I suspect another deadline will arise after the Nevada case ends with an undisclosed settlement. That's the history of DECN I'm familiar with.
The only thing level two has shown since the settlement and the resultant 50% plus plunge in share price is that there have been more sellers than buyers.
For years we have been waiting for the primary case to have been settled when DECN share price would explode. Since we learned that the size of the settlement was no larger than the expense of a legal retainer, the share price has acted more like a plutonium implosion, and all we get are excuses for this.
What good are "victories" and "accomplishments" that result in the share price plummeting over 50%?
Isn't the information that is revealed in those documents more important than how Scoop obtained them?
Izzy - For about five years now, the posted expectations were that JNJ was going to have to pay DECN such a huge amount of money that upon announcement of the settlement the share price of DECN would be catapulted immediately into dollars. The figure of $8 was mentioned many times as a realistic short term price. Also, it was expected that JNJ would be responsible for DECN's court costs, which were also said to be very low because their legal team had agreed upon a contingency fee.
As it turned out, the amount of the settlement has been been concealed and KB announced that the entirety of the settlement would be set aside for future legal fees, and not be put into production and marketing of their new announced product. Unless, DECN management is expecting huge legal fees in the future, the settlement was clearly not anywhere near what was expected. Meanwhile, DECN's share price has plummeted over 50% from where it was in anticipation of the settlement.
It would seem that the only pummeling that has been given out has been to DECN shareholders. People being upset about this is hardly silly or suspicious.
There's been recent inside buying as well.
I bought at .019 a few days ago. It hasn't traded under .02 since, but it hasn't traded that much.
I'm new to this stock. What's the joke?
JNJ (with whom DECN is in legal suits) is rated #1 on Barron's list of the world's most respected companies.
Those were my .019s. Looks like I may have gotten in just in the nick of time.
This isn't a court of law.
DECN up today to .26.
From what I've read in the pr's and from people in-the-know who post here, Berman is working primarily out of his concern for "the diabetic community."
Will those payments also go into a litigation fund to protect themselves from shareholder lawsuits like the first settlement did?
In our disagreement about the settlement between JNJ and DECN, let's keep in mind that in the few weeks since it came down, DECN has lost over half of its share value and JNJ is trading at its historical high.
That probably says more about what happened than anything you or I can say.
Something I'm sure that we already do agree on is the definition of the word "nuisance."
Yes, that's exactly what I'm suggesting.
It was the announcement of that suit against JNJ that helped pump DECN up to .60. The dump is still in process and the mighty, powerful DECN is languishing at .25 and sinking.
It was your word: DECN is no more than a nuisance to JNJ, one of the unpleasant costs of doing business.
JNJ is trading at its all time high, even after having been "beaten" so badly by DECN.
Just because DECN has asked for 4-700 mil doesn't necessarily mean they will receive anything.
Don't count your lawsuits until they've been settled.
I believe they filed that to get "longs" and potential investors excited.
Do you remember this from JNJ's press release in May:
The company's consumer medical device businesses have leading positions and are poised for growth. Johnson & Johnson Vision Care, the global market leader in contact lenses, expects to grow market share and exceed the industry pace of innovation by delivering two new products per year through 2020. The Johnson & Johnson Diabetes Care Companies, market leading in blood glucose monitoring, are increasing their competitiveness and expect improved market penetration globally to reach more patients. Combined, these businesses have a robust innovation agenda with a current pipeline of products expected to be filed for regulatory approval by 2018, with sales potential greater than $2 billion.
Not really, but CETX might very well have a lot more juice in it.
Obrien mentioned AMPG.
Thanks, O'.
Hey Obrien -- What's supposed to happen here to make this puppy grow?
It's not how well you mow, Dank. It's how well you mow fast.
JNJ clearly gave its suit with DECN all the attention they felt it deserved. JNJ is a massive company, and they clearly consider this a minor concern over a single product in one of their divisions. Considering the minor amount of the settlement, their consideration seems correct.
Can you give me one example of "a dividend to shareholders" by any corporation that received a huge settlement?
Oh right, mongoose, Genultimate is going to tear up the market. Retailers are going to be tripping all over themselves to get it on their shelves. Any day now.
Thanks for preparing everyone for the inevitable explanation of why Walmart won't be carrying Genultimate (or whatever name it's using now) anytime this year. It doesn't mean they won't be carrying it next year, right.
I've kept quiet about it, thinking if God didn't know I owned it, it had a better chance of performing. But I don't think She reads OTCbargains' thread.
It's my largest holding too, and I'm ready for three too. I lurk the CETX board and enjoy your contributions, OBrien
I don't know what you just said but I stand by what I said: In my opinion the settlement was sealed at DECN's, not JNJ's request.
I think you'll like what you find with CETX. It's got a small float so it's pretty volatile. 52 week range is something like 1.60-5.00. I'll be curious to hear what you think, if you have time.
I bought a little of both MLGT and RJDG, was hoping for a quick flip, but am willing to sit on them for a bit.
I mostly switched to much larger caps some time ago but still visit the pennies, and still hold 5-6.
I strongly suggest you look into CETX.
Happy trails, Bargain, and good luck.
...do you really think J&J wants to disclose any $ sum...and announce a "stick in the eye"?
We've been 3-6 months away from the big payoff for the last five years now.
Impossible to guess when, or if, they make a retail agreement.
Impossible for me or anybody else to guess. DECN has promised so many things that never came to pass.
Those lawyers must charge a heck of a lot, or the settlement couldn't have been very big.